From: Efficacy of monoclonal antibodies against CGRP in migraine patients with fibromyalgia comorbidity: a retrospective monocentric observational study
Age (years)
Sex
Type of migraine
FM
43.5 ± 8.9
1 m, 25 f
21 chronic, 5 episodic (8 with MOH)
No FM
44.1 ± 7.5
19 m, 77 f
30 chronic, 66 episodic (12 with MOH)
Anova F 0.08 n.s
Chi square 3.8 p 0.051
Chi square 0.91 p 0.338